MYEF2 (Myelin Expression Factor 2) is a transcription repressor known to play a significant role in the regulation of gene expression related to myelin, which is the insulating layer that forms around nerves, including those in the brain and spinal cord. The protein is involved in the complex process of myelination, which is critical for the proper functioning of the nervous system, facilitating rapid and efficient transmission of electrical signals along nerve cells. MYEF2's function extends beyond myelination, as it has been implicated in various cellular processes, including the regulation of apoptosis and cellular differentiation. By influencing the expression of genes involved in these processes, MYEF2 contributes to the maintenance of cellular homeostasis and the development of the nervous system. The regulation of MYEF2 activity is therefore a crucial aspect of its function, as it ensures the precise control of gene expression patterns necessary for normal cellular and physiological processes.
The activation of MYEF2 involves a series of biochemical and molecular mechanisms that enable its function as a transcription repressor. Phosphorylation is a key regulatory mechanism that modulates MYEF2 activity. Specific kinases target MYEF2, adding phosphate groups that can alter its conformation and its interaction with DNA and other regulatory proteins. This post-translational modification can enhance MYEF2's ability to bind to target gene promoters, repressing or activating their transcription in response to cellular signals. Additionally, MYEF2 activation can be influenced by changes in intracellular signaling pathways, such as those mediated by growth factors, hormones, and other extracellular cues. These signals can lead to the modification of MYEF2 or its cofactors, adjusting its transcriptional activity to meet the dynamic needs of the cell. The interplay between phosphorylation, protein-protein interactions, and intracellular signaling cascades ensures that MYEF2 can precisely regulate gene expression in response to developmental cues and environmental changes, highlighting its importance in neural development and function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Influences gene transcription, potentially affecting MYEF2 expression. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
Can modulate transcriptional activity in certain contexts. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Influences gene expression via glucocorticoid receptors. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Elevates cAMP levels which can influence gene transcription. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
HDAC inhibitor, influencing gene transcription. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
PPARγ agonist, influencing gene transcription pathways. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Calcium ionophore modulating various pathways, potentially affecting MYEF2. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Protein kinase inhibitor influencing multiple pathways. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
DNA methyltransferase inhibitor which can affect gene transcription. | ||||||